Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid

Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid

The aim of this study was to determine the utility of brolucizumab in the management of choroidal neovessels (CNV) with a retinal pigment epithelial (RPE) tear and subretinal fluid. We used a case series of patients with CNV who developed an RPE tear either spontaneously or following an intravitreal...

Full description

Bibliographic Details
Main Authors: Alper Bilgic, Laurent Kodjikian, Shail Vasavada, Shyamal Jha, Samaresh Srivastava, Aditya Sudhalkar, Thibaud Mathis
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
age-related macular degeneration
anti-vascular endothelial growth factor
brolucizumab
epithelial tear
exudation
optical coherence tomography
Online Access:https://www.mdpi.com/2077-0383/10/11/2425

Internet

https://www.mdpi.com/2077-0383/10/11/2425

Similar Items